News | Cath Lab | August 17, 2016

Minnesota Hospital Receives Cath Lab Upgrades from Corindus, Acist

Robotic therapy, rapid exchange FFR and automated contrast delivery provide advanced workflow solutions at Fairview Southdale Hospital

Corindus Corpath, Acist Medical RXi and CVi, Fairview Southdale Hospital, Minnesota, cath lab

August 17, 2016 — Corindus Vascular Robotics Inc. and Acist Medical Systems Inc. are providing Fairview Southdale Hospital, Edina, Minn., with three technologies that improve workflow in the cardiac cath lab. This includes the CorPath System from Corindus, and Acist’s RXi and CVi technologies.

"I am excited to work with both companies to bring innovative solutions to the cath lab that enhance patient care," said Gregory Helmer, M.D., FACC, co-director of medical research, Fairview Southdale Hospital. "Rapid FFR and robotic PCI are significant contributions to PCI procedures and may improve safety, lesion assessment, and bring further precision to our interventional procedures."

The CorPath System is the first U.S. Food and Drug Administration (FDA)-cleared robotic-assisted system for percutaneous coronary intervention (PCI), offering robotic precision that may improve clinical outcomes and protection for physicians and staff from serious occupational hazards in the cath lab. The Acist RXi technology provides the reassurance of accurate and reliable fractional flow reserve (FFR) measurements and the advantages of Rapid Exchange technology. Acist CVi simplifies contrast injection for procedures while enhancing safety, efficiency, control and image quality.

For more information: www.corindus.com, www.acist.com

Related Content

Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
SCAI Updates Consensus on Length of Stay for Percutaneous Coronary Intervention
News | Cath Lab | May 15, 2018
Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutaneous coronary...
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab | May 15, 2018
May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal c
Angiogram of a STEMI patient.
News | Cath Lab | May 15, 2018
May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used
Recent Acquisitions Eroding Prices in Billion Dollar European Interventional Cardiology cath lab Market.
Feature | Cath Lab | May 07, 2018 | Simon Trinh and Jeffrey Wong
The European interventional cardiology market is currently valued at nearly $1.4 billion.
Videos | Cath Lab | May 07, 2018
Imran Ahmad, M.D., medical director of interventional cardiology, explains some of the new technologies his labs have
360 Photos | Cath Lab | April 20, 2018
A 360 degree view of the newest cath lab at Northwestern Medicine Central DuPage Hospital in Winfield, Ill., located
SCAI Announces Global Lecture Series for 2018 Scientific Sessions
News | Cath Lab | April 18, 2018
Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego,...
Overlay Init